| abstract |
The present invention relates to a combination comprising: (i) a renin inhibitor, or a pharmaceutically acceptable salt thereof; (ii) a neutral endopeptidase (NEP) inhibitor, or a pharmaceutically acceptable salt thereof; and optionally at least one therapeutic agent selected from the group consisting of (a) a diuretic, or a pharmaceutically acceptable salt thereof; and (b) an angiotensin II receptor blocker (ARB), or a pharmaceutically acceptable salt thereof; for the prevention of, delay the onset of and/or treatment of a disease or a condition mediated by angiotensin II and/or NEP activity, which method comprises administering to a warm-blooded animal, in need thereof, a therapeutically effective amount of a combination of the present invention. |